Weiss, J., Kaczmar, J. M., Harrington, K. J., Mehra, R., Worden, F. P., Zinner, R., Giri, A., Kang, H., Pham, D. C., Najeeb, S., Bhateja, P., Panella, T. J., Sukari, A., Kaur, V., Grewal, J. S., Schaaf, D., Jones, S., Price, K. A. R. (2025). Versatile-002: Overall survival of HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6037